Zynfusion appoints new CEO to lead company to commercialization

Alan Condon -   Print  |

Spinal device company Zynfusion appointed Mark Terrill as CEO May 26.

Mr. Terrill replaces Amit Mehta, MD, who is assuming the role of chairman of the board.

Most recently, he served as CEO of ARC Devices, a digital health medical technology company.

Mr. Terrill will be responsible for leading the company from the product development stage to commercialization and revenue generation.

More articles on devices:
Cleveland Clinic neurosurgeon joins Centerline Biomedical advisory board
Some spine surgeons wouldn't disclose if they had COVID-19, study says
Which physicians have the most claims denied, resubmitted? A specialty breakdown

© Copyright ASC COMMUNICATIONS 2020. Interested in LINKING to or REPRINTING this content? View our policies here.

Featured Webinars

Featured Whitepapers